Skip to main content
. 2021 Nov 12;10(11):3141. doi: 10.3390/cells10113141

Table 2.

Discriminatory metabolic features with confirmed molecular identities.

m/z RT (sec) Verified Metabolite or Metabolite Class Metabolite
Identification Level
AMD/
Controls
Fold Change
IAMD/
Controls Fold Change
NVAMD/
IAMD
Fold Change
Acylcarnitines
414.3568 377.7 Heptadecanoyl carnitine 2 - - 2.08
426.3568 366.5 11Z-Octadecenylcarnitine 2 - - 1.74
424.3419 345.9 Linoleyl carnitine 2 - - 1.75
422.3270 330.5 Linolenyl carnitine * 2 1.63 - -
274.1263 373.8 Glutaconylcarnitine 2 1.49 - -
428.3721 392.6 Stearoylcarnitine 2 - - 1.83
Lipid metabolites
466.3518 332.9 LysoSM (d18:1) * 2 - - 2.34
516.3057 376.2 LysoPC (18:4) * 2 1.47 - -
324.2893 471.0 Linoleoyl ethanolamide 2 1.32 - -
326.3045 526.9 N-Oleoylethanolamine 2 1.37 - -
Steroids and steroid derivatives
413.3451 351.0 25-Hydroxyvitamin D2 2 - - 2.16
347.2213 271.9 Cortexolone 2 3.12 - -
Amino acid-related metabolites
130.0499 51.9 Pyroglutamic acid 1 1.52 - -
209.0910 234.1 Kynurenine 1 - - 0.72

Discriminatory metabolic features were identified by PLS-DA (VIP ≥ 2.0) and linear regression analysis (FDR < 0.1 and p < 0.05). To verify their molecular identities, features were compared with an in-house library of metabolic features whose molecular identities had previously been confirmed. A subset of previously unconfirmed metabolites was evaluated by LC–MS/MS. * molecular identity newly confirmed in this study; m/z: mass-to-charge ratio; RT (sec): retention time (seconds).